Natural history of Idiopathic Recurrent Acute Pancreatitis (IRAP): a prospective “real world” cohort study

Pancreatology ◽  
2019 ◽  
Vol 19 ◽  
pp. S55
Author(s):  
Kshaunish Das ◽  
Sujay Ray ◽  
Dilip Bhattacharya ◽  
Sukanta Ray ◽  
Partha Sarathi Patra
Pancreatology ◽  
2014 ◽  
Vol 14 (3) ◽  
pp. S98-S99
Author(s):  
Giulia Martina Cavestro ◽  
Leandro Gioacchino ◽  
Milena Di Leo ◽  
Raffaella Alessia Zuppardo ◽  
Olivia B. Morrow ◽  
...  

Pancreatology ◽  
2016 ◽  
Vol 16 (5) ◽  
pp. 770-777 ◽  
Author(s):  
Rohit Das ◽  
Bridger Clarke ◽  
Gong Tang ◽  
Georgios I. Papachristou ◽  
David C. Whitcomb ◽  
...  

2016 ◽  
Vol 83 (5) ◽  
pp. AB142
Author(s):  
Rohit Das ◽  
Bridger Clarke ◽  
Gong Tang ◽  
Georgios I. Papachristou ◽  
David C. Whitcomb ◽  
...  

2015 ◽  
Vol 47 (3) ◽  
pp. 205-210 ◽  
Author(s):  
Giulia Martina Cavestro ◽  
Gioacchino Leandro ◽  
Milena Di Leo ◽  
Raffaella Alessia Zuppardo ◽  
Olivia B. Morrow ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A128-A128 ◽  
Author(s):  
H MALATY ◽  
D GRAHAM ◽  
A ELKASABANY ◽  
S REDDY ◽  
S SRINIVASAN ◽  
...  

2021 ◽  
Vol 20 (1) ◽  
Author(s):  
Robert J. Sanchez ◽  
Wenzhen Ge ◽  
Wenhui Wei ◽  
Manish P. Ponda ◽  
Robert S. Rosenson

Abstract Background This retrospective cohort study assessed the annualized incidence rate (IR) of acute pancreatitis (AP) in a nationally representative US adult population, as well as the variation in the risk of AP events across strata of triglyceride (TG) levels. Methods Data were obtained from IQVIA’s US Ambulatory Electronic Medical Records (EMR) database linked with its LRxDx Open Claims database. Inclusion criteria included ≥1 serum TG value during the overlapping study period of the EMR and claims databases, ≥1 claim in the 12-month baseline period, and ≥ 1 claim in the 12 months post index. All TG measurements were assigned to the highest category reached: < 2.26, ≥2.26 to ≤5.65, > 5.65 to ≤9.94, > 9.94, and > 11.29 mmol/L (< 200, ≥200 to ≤500, > 500 to ≤880, > 880, and > 1000 mg/dL, respectively). The outcome of interest was AP, defined as a hospitalization event with AP as the principal diagnosis. Results In total, 7,119,195 patients met the inclusion/exclusion criteria, of whom 4158 (0.058%) had ≥1 AP events in the prior 12 months. Most patients (83%) had TGs < 2.26 mmol/L (< 200 mg/dL), while < 1% had TGs > 9.94 mmol/L (> 880 mg/dL). Overall, the IR of AP was low (0.08%; 95% confidence internal [CI], 0.08–0.08%), but increased with increasing TGs (0.08% in TGs < 2.26 mmol/L [< 200 mg/dL] to 1.21% in TGs > 11.29 mmol/L [> 1000 mg/dL]). In patients with a prior history of AP, the IR of AP increased dramatically; patients with ≥2 AP events at baseline had an IR of 29.98% (95% CI, 25.1–34.9%). Conclusion The risk of AP increases with increasing TG strata; however, the risk increases dramatically among patients with a recent history of AP.


Sign in / Sign up

Export Citation Format

Share Document